We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Gene Variant Plus Stress Increase Depression Risk

By Biotechdaily staff writers
Posted on 25 Jul 2003
A study has found that among people who experience stressful events over five years, 43% of those with a short version of the serotonin transporter gene develop depression, compared to only 17% of those with a long version of the gene. More...
The findings were reported in the July 18, 2003, issue of Science.

Researchers followed 847 Caucasian New Zealanders, born in the early 1970s, from birth into adulthood. They found that 17% carried two copies of the stress-sensitive short version, 31% carried two copies of the protective long version, and 51% carried one copy of each version. After charting stressful life events from ages 21-26, such as homelessness, disabling injuries, debt, relationship problems, and abuse, they found that 17% of participants had a diagnosis of a major depression in the past year, and 3% had either attempted or thought about suicide. Carriers of the short version represented only 10% of the participants. Such events failed to predict a diagnosis of depression among those with two copies of the long variant.

Since the most widely prescribed class of antidepressants act by blocking the serotonin transporter gene, it has been a prime suspect in mood and anxiety disorders. However, eight previous studies did not detect its link to depression.

"We found the connection only because we looked at the study members' stress history,” noted Dr. Terrie Moffitt, of King's College London (UK), who conducted the research along with colleagues from King's College and the University of Wisconsin (Madison, USA).





Related Links:
King's College London
U. of Wisconsin

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Automated Clinical Chemistry Analyzer
Envoy 500+
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.